Antibacterial cephalosporin compounds
    5.
    发明授权
    Antibacterial cephalosporin compounds 失效
    抗生素CEPHOROSPORIN化合物

    公开(公告)号:US5189157A

    公开(公告)日:1993-02-23

    申请号:US189936

    申请日:1988-05-03

    摘要: There are presented antibacterial cephalosporins having broad antimicrobial activity as well as intermediates for their formation, such compounds having the formula ##STR1## wherein X is ##STR2## R is hydrogen or a carboxylic acid protecting group; R.sub.1 is hydrogen or an acyl group;R.sub.2 is hydrogen or lower alkoxy; andR.sub.3 is carbocyclic aryl or alkyl carbocyclic aryl substituted on the ring with two or more of hydroxy and/or lower alkanoyl ester groups, with halogen being an optional additional ring substituent;as well as the corresponding readily hydrolyzable esters, pharmaceutically acceptable salts and hydrates of these compounds where R is hydrogen.

    摘要翻译: 呈现具有广谱抗微生物活性的抗菌头孢菌素及其形成中间体,具有下式的化合物,其中X为氢或羧酸保护基; R1是氢或酰基; R2是氢或低级烷氧基; 并且R 3是在具有两个或多个羟基和/或低级烷酰基酯基团的环上被取代的碳环芳基或烷基碳环基,其中卤素是任选的另外的环取代基; 以及其中R是氢的这些化合物的相应的易水解的酯,药学上可接受的盐和水合物。

    Cephem-3-imidates and 3-amidines
    8.
    发明授权
    Cephem-3-imidates and 3-amidines 失效
    Cephem-3-imidates和3-脒基

    公开(公告)号:US4560749A

    公开(公告)日:1985-12-24

    申请号:US552960

    申请日:1983-11-18

    申请人: Douglas O. Spry

    发明人: Douglas O. Spry

    IPC分类号: C07D501/18 C07D501/38

    CPC分类号: C07D501/18 C07D501/38

    摘要: 3-Azido-3-cephem esters are reacted with electron rich olefins, e.g., enamines and cyclic enol ethers, to provide C.sub.3 amidines and imidates having antibacterial activity in the free acid form. For example, 3-azido-3-cephem esters react with ethyl vinyl ether to provide 3-[1-(ethoxyethylidene)amino]-3-cephem esters. The latter are deesterified to provide the free acid antibacterials.

    摘要翻译: 3-亚氨基-3-头孢烯酯与富含烯烃的烯烃(例如烯胺和环烯醇醚)反应,以提供具有游离酸形式的抗菌活性的C 3脒和亚胺化物。 例如,3-叠氮基-3-头孢烯酯与乙基乙烯基醚反应,得到3- [1-(乙氧基亚乙基)氨基] -3-头孢烯酯。 后者被酯化以提供游离酸抗菌剂。

    Cephalosporins having a 7-(carboxy substituted .alpha.-etherified
oximinoarylacetamido) group
    9.
    发明授权
    Cephalosporins having a 7-(carboxy substituted .alpha.-etherified oximinoarylacetamido) group 失效
    头孢菌素具有7-(羧基取代的{60-乙酰肟基芳基乙酰胺基)基团

    公开(公告)号:US4168309A

    公开(公告)日:1979-09-18

    申请号:US838366

    申请日:1977-09-30

    申请人: Barry E. Ayres

    发明人: Barry E. Ayres

    CPC分类号: C07D501/38

    摘要: Antibiotic compounds of the general formula ##STR1## [wherein R is a phenyl, thienyl or furyl group; R.sup.a and R.sup.b which may be the same or different, are each selected from hydrogen, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.3-7 cycloalkyl, phenyl, naphthyl, thienyl, furyl, carboxy, C.sub.2-5 alkoxycarbonyl and cyano, or R.sup.a and R.sup.b together with the carbon atom to which they are attached form a C.sub.3-7 cycloalkylidene or cycloalkenylidene group; m or n are each 0 or 1 such that the sum of m and n is 0 or 1; and R.sup.1 together with the nitrogen atom to which it is attached form a saturated or partially saturated 4-10 membered heterocyclic ring which may contain one or more further heteroatoms selected from 0,N and S and which may be substituted by a lower alkyl, lower alkoxy, lower acyloxy, lower alkoxycarbonyl, hydroxy, carboxy, amino, acylamino, substituted or unsubstituted carbamoyl or aryl group, or such a heterocyclic ring fused with a benzene ring] and non-toxic derivatives thereof, the compounds being syn isomers or existing as mixtures of syn and anti isomers.

    摘要翻译: 通式(I)的抗生素化合物[其中R是苯基,噻吩基或呋喃基; R a和R b可以相同或不同,各自选自氢,C 1-4烷基,C 2-4烯基,C 3-7环烷基,苯基,萘基,噻吩基,呋喃基,羧基,C 2-5烷氧基羰基和氰基,或 R a和R b与它们所连接的碳原子一起形成C 3-7亚环烷基或亚环烯基; m或n各自为0或1,使得m和n的和为0或1; 并且R 1与其连接的氮原子一起形成饱和或部分饱和的4-10元杂环,其可以含有一个或多个另外的选自O,N和S的杂原子,并且其可以被低级烷基取代,低级烷基 烷氧基,低级酰氧基,低级烷氧基羰基,羟基,羧基,氨基,酰氨基,取代或未取代的氨基甲酰基或芳基,或与苯环稠合的杂环]及其无毒衍生物,所述化合物为顺式异构体或存在 顺式和反式异构体的混合物。

    7-(.alpha.-Sulfoacylamido)cephalosporins
    10.
    发明授权
    7-(.alpha.-Sulfoacylamido)cephalosporins 失效
    7 - ({60-磺酰基氨基)头孢菌素

    公开(公告)号:US4065619A

    公开(公告)日:1977-12-27

    申请号:US719704

    申请日:1976-09-02

    CPC分类号: C07D501/38

    摘要: Novel cephalosporins of the formula, ##STR1## wherein R is a hydrogen atom or an alkyl, aryl or thienyl group, and R' is a group which constitutes together with the adjacent nitrogen atom a 5- or 6-membered ring containing 1 or 2 nitrogen atoms, which are effective particularly against Pseudomonas aeruginosa as well as against other Gram negative and positive microorganisms, for example, N-[7-(.alpha.-sulfophenylacetamido)ceph-3-em-3-ylmethyl] pyridinium 4-carboxylate, N-[7-(.alpha.-sulfo-3'-thienylacetamido)ceph-3-em-3-ylmethyl] pyridinium-4-carboxylate, and their pharmaceutically acceptable salts thereof. Sodium salt of the former is prepared by, e.g. reacting sodium 7-(.alpha.-sulfophenylacetamido) cephalosporanate with pyridine in water.

    摘要翻译: 新颖的下式头孢菌素其中R是氢原子或烷基,芳基或噻吩基,R'是与相邻氮原子一起构成含有1或2的5-或6-元环的基团 氮原子,其特别对绿脓假单胞菌以及其他革兰氏阴性和阳性微生物有效,例如N- [7-(α-磺基苯基乙酰氨基)头孢-3-烯-3-基甲基]吡啶鎓4-羧酸盐,N - [7-(α-磺基-3'-噻吩基乙酰胺基)头孢-3-烯-3-基甲基]吡啶鎓-4-羧酸盐及其药学上可接受的盐。 前者的钠盐通过例如 使7-(α-磺基苯基乙酰氨基)头孢菌素钠与吡啶在水中反应。